Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection. [electronic resource]
Producer: 20100914Description: 2534-9 p. digitalISSN:- 1098-6596
- Anti-Bacterial Agents -- administration & dosage
- Area Under Curve
- Aza Compounds -- administration & dosage
- Cell Line
- Colony Count, Microbial
- Fluoroquinolones
- Half-Life
- Humans
- In Vitro Techniques
- Microbial Sensitivity Tests
- Models, Biological
- Monte Carlo Method
- Moxifloxacin
- Mycobacterium avium Complex -- drug effects
- Mycobacterium avium-intracellulare Infection -- drug therapy
- Protein Binding
- Quinolines -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.